Publication & Citation Trends
Publications
151 total
Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion OA
Cited by 2
Semantic Scholar
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression PDF
Cited by 542
OpenAlex
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials PDF
Cited by 143
OpenAlex
Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Cited by 162
OpenAlex
Gemeinsame Stellungnahme zur Herausnahme der Hepatitis-C-Antikörpertestung aus den extrabudgetären Laborleistungen (EBM-Ziffer 32006)
Cited by 0
Semantic Scholar
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
Cited by 141
OpenAlex
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe PDF
Cited by 173
OpenAlex
Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01) PDF
Cited by 73
OpenAlex
Research Topics
Hepatitis C virus research
(93)
Liver Disease Diagnosis and Treatment
(42)
Hepatitis B Virus Studies
(39)
HIV/AIDS drug development and treatment
(38)
HIV Research and Treatment
(25)
Affiliations
German Sport University Cologne
University of Freiburg
East Carolina University
Zuse Institute Berlin
University of California, Irvine